Skip to main content
ImmuneCited

Arginine methylation in the epithelial-to-mesenchymal transition.

Jian Qin, Jian Xu
Review The FEBS journal 2022 8 Zitierungen
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D34358413'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
Review
Population
None
Intervention
Arginine methylation in the epithelial-to-mesenchymal transition. None
Vergleichsgruppe
None
Primärer Endpunkt
None
Wirkungsrichtung
Mixed
Verzerrungsrisiko
Unclear

Abstract

Epithelial cells acquire mesenchymal characteristics during embryonic development, wound healing, fibrosis, and in cancer in a processed termed epithelial-to-mesenchymal transition (EMT). Regulatory networks of EMT are controlled by post-transcriptional, translational, and post-translational mechanisms, in which arginine methylation is critically involved. Here, we review arginine methylation-dependent mechanisms that regulate EMT in the aspects of signaling, transcriptional, and splicing regulation.

Zusammenfassung

Arginine methylation‐dependent mechanisms that regulate EMT in the aspects of signaling, transcriptional, and splicing regulation are reviewed.

Used In Evidence Reviews

Similar Papers